Neptune Wellness Solutions (NASDAQ:NEPT) Posts Earnings Results, Misses Expectations By $0.03 EPS

Neptune Wellness Solutions (NASDAQ:NEPT) (TSE:NTB) issued its quarterly earnings data on Wednesday. The biotechnology company reported ($0.06) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.03), Morningstar.com reports. The company had revenue of $3.26 million for the quarter, compared to analysts’ expectations of $4.51 million. Neptune Wellness Solutions had a negative return on equity of 19.34% and a negative net margin of 94.47%.

NEPT traded down $0.24 during trading on Thursday, hitting $4.58. The company’s stock had a trading volume of 49,574 shares, compared to its average volume of 2,025,961. Neptune Wellness Solutions has a twelve month low of $2.42 and a twelve month high of $6.57. The business’s fifty day moving average price is $5.11. The company has a market cap of $445.61 million, a price-to-earnings ratio of -32.79 and a beta of 1.67.

Institutional investors and hedge funds have recently modified their holdings of the business. Two Sigma Advisers LP acquired a new stake in Neptune Wellness Solutions in the fourth quarter valued at approximately $367,000. Deutsche Bank AG grew its holdings in Neptune Wellness Solutions by 245.9% in the fourth quarter. Deutsche Bank AG now owns 517,135 shares of the biotechnology company’s stock valued at $1,313,000 after purchasing an additional 367,614 shares during the period. Alpine Group USVI LLC acquired a new stake in Neptune Wellness Solutions in the first quarter valued at approximately $303,000. CIBC World Markets Inc. acquired a new stake in Neptune Wellness Solutions in the first quarter valued at approximately $63,000. Finally, Jane Street Group LLC grew its holdings in Neptune Wellness Solutions by 45.9% in the second quarter. Jane Street Group LLC now owns 22,598 shares of the biotechnology company’s stock valued at $98,000 after purchasing an additional 7,106 shares during the period. 12.22% of the stock is currently owned by institutional investors.



A number of equities research analysts have commented on the company. BidaskClub cut Neptune Wellness Solutions from a “buy” rating to a “hold” rating in a research note on Tuesday. Echelon Wealth Partners restated a “buy” rating on shares of Neptune Wellness Solutions in a research note on Wednesday, July 24th. Finally, Zacks Investment Research raised Neptune Wellness Solutions from a “hold” rating to a “buy” rating and set a $5.50 target price on the stock in a report on Wednesday.

About Neptune Wellness Solutions

Neptune Wellness Solutions Inc, a health and wellness products company, specializes in the extraction, purification and formulation of cannabis products, as well as other specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils.

See Also: What is the strike price in options trading?

Earnings History for Neptune Wellness Solutions (NASDAQ:NEPT)

Receive News & Ratings for Neptune Wellness Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neptune Wellness Solutions and related companies with MarketBeat.com's FREE daily email newsletter.